✦ LIBER ✦

Eliglustat for Gaucher disease Type 1 (GD1): Safety results from a Phase 2 study after 2 years of treatment

✍ Scribed by M. Judith Peterschmitt; Elena Lukina; Nora Watman; Marta Dragosky; Marcelo Iastrebner; Gregory Pastores; Elsa Avila Arreguin; Hanna Rosenbaum; Mici Phillips; Mathilde Kaper; Dominique Bertin-Millet; Ana Cristina Puga

Book ID: 116989214
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 102
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2010.11.118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eliglustat, an Investigational Oral Ther

Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1 (GD1): Updated Phase 2 Results

✍ M. Judith Peterschmitt; Elena Lukina; Nora Watman; Marta Dragosky; Marcelo Iastr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Eliglustat, an investigational oral ther

Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4years of treatment

✍ Lukina, Elena; Watman, Nora; Dragosky, Marta; Pastores, Gregory M.; Arreguin, El 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Eliglustat, an investigational oral ther

Eliglustat, an investigational oral therapy for gaucher disease type 1 (GD1): Phase 2 results and assessment of patient responses and achievement of established therapeutic goals after 2 years of treatment

✍ Ana Cristina Puga; Elena Lukina; Nora Watman; Marta Dragosky; Marcelo Lastrebner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Eliglustat, an investigational oral ther

Eliglustat, an investigational oral therapy for Gaucher disease type 1 (GD1): Phase 2 results and assessment of patient responses and achievement of established therapeutic goals after 2 years of treatment

✍ Marta Dragosky; Elena Lukina; Nora Watman; Gregory Pastores; Marcelo Iastrebner; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

A phase 3, randomized, double-blind, pla

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

✍ Mistry, Pramod; Lukina, Elena; Dridi, Marie-Françoise Ben; Amato, Dominick; Bari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Latest data on Genz-112638, an investiga

Latest data on Genz-112638, an investigational oral therapy for type 1 Gaucher disease: Phase II clinical trial results after 1 year of treatment

✍ Elena Lukina 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 298 KB